"The most severe effects of Vitamin A deficiency are seen in young children and pregnant women in low-income countries," ...

A study shows pain coping skills training (PCST) significantly alleviates chronic pain in dialysis patients, enhancing their quality of life.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 supplements.

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...